SE8203814L - Prolinderivat och forfarande for framstellning derav - Google Patents

Prolinderivat och forfarande for framstellning derav

Info

Publication number
SE8203814L
SE8203814L SE8203814A SE8203814A SE8203814L SE 8203814 L SE8203814 L SE 8203814L SE 8203814 A SE8203814 A SE 8203814A SE 8203814 A SE8203814 A SE 8203814A SE 8203814 L SE8203814 L SE 8203814L
Authority
SE
Sweden
Prior art keywords
proline derivatives
group
alpha
amino acid
procedures
Prior art date
Application number
SE8203814A
Other languages
English (en)
Other versions
SE453595B (sv
Inventor
S Tanaka
K Kuromaru
Y Fujimura
I Matsunaga
T Iwaoka
N Obatake
J Aono
Y Hinohara
H Nakano
M Fukushima
H Nabata
K Sakai
S-I Hata
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP56094002A external-priority patent/JPS57209270A/ja
Priority claimed from JP56137823A external-priority patent/JPS5839661A/ja
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of SE8203814L publication Critical patent/SE8203814L/sv
Publication of SE453595B publication Critical patent/SE453595B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE8203814A 1981-06-19 1982-06-18 Prolinderivat SE453595B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP56094002A JPS57209270A (en) 1981-06-19 1981-06-19 Proline derivative
JP56137823A JPS5839661A (ja) 1981-09-03 1981-09-03 プロリン誘導体の製法

Publications (2)

Publication Number Publication Date
SE8203814L true SE8203814L (sv) 1982-12-20
SE453595B SE453595B (sv) 1988-02-15

Family

ID=26435270

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8203814A SE453595B (sv) 1981-06-19 1982-06-18 Prolinderivat

Country Status (19)

Country Link
KR (1) KR890000769B1 (sv)
AT (1) AT377496B (sv)
CA (1) CA1235120A (sv)
CH (1) CH651825A5 (sv)
DE (1) DE3222779A1 (sv)
DK (1) DK156054C (sv)
ES (2) ES513277A0 (sv)
FI (1) FI75804C (sv)
FR (1) FR2508040B1 (sv)
GB (1) GB2102412B (sv)
HU (1) HU188177B (sv)
IL (1) IL65954A (sv)
IT (1) IT1157053B (sv)
MX (2) MX171888B (sv)
NL (1) NL193282C (sv)
NO (1) NO156408C (sv)
PT (1) PT75076B (sv)
SE (1) SE453595B (sv)
SU (1) SU1316556A3 (sv)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6354321A (ja) * 1985-03-27 1988-03-08 Ajinomoto Co Inc 血糖降下剤
KR870007114A (ko) * 1986-01-21 1987-08-14 우에노 기미오 티올 에스테르 유도체의 안정된 고형제
ZA896851B (en) 1988-09-14 1990-06-27 Hoffmann La Roche Use of ace-inhibitors
EP0634175B1 (de) * 1993-07-15 2001-01-10 F. Hoffmann-La Roche Ag Pharmazeutische Kombination, die einen Hemmer des Renin-Angiotensin-Systems und einen Endothelin-Antagonisten enthält

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA802420B (en) * 1979-05-18 1981-04-29 Squibb & Sons Inc Aminoacyl derivatives of mercaptoacyl amino acids

Also Published As

Publication number Publication date
NL8202472A (nl) 1983-01-17
DK273082A (da) 1982-12-20
DE3222779A1 (de) 1983-01-27
FI75804B (fi) 1988-04-29
HU188177B (en) 1986-03-28
FI75804C (sv) 1988-08-08
NO156408B (no) 1987-06-09
FR2508040B1 (fr) 1986-07-04
NO156408C (no) 1987-09-16
CA1235120A (en) 1988-04-12
PT75076B (en) 1984-05-09
AT377496B (de) 1985-03-25
ATA558581A (de) 1984-08-15
MX155724A (es) 1988-04-20
IL65954A (en) 1986-03-31
SU1316556A3 (ru) 1987-06-07
GB2102412A (en) 1983-02-02
FI822171L (fi) 1982-12-20
NL193282C (nl) 1999-05-06
FR2508040A1 (fr) 1982-12-24
ES8307216A1 (es) 1983-07-01
NO821997L (no) 1982-12-20
ES520582A0 (es) 1984-04-01
CH651825A5 (de) 1985-10-15
IL65954A0 (en) 1982-09-30
ES8403868A1 (es) 1984-04-01
DE3222779C2 (sv) 1991-01-03
SE453595B (sv) 1988-02-15
MX171888B (es) 1993-11-23
PT75076A (en) 1982-07-01
IT8267772A0 (it) 1982-06-16
DK156054B (da) 1989-06-19
FI822171A0 (fi) 1982-06-16
IT1157053B (it) 1987-02-11
KR840000488A (ko) 1984-02-22
KR890000769B1 (ko) 1989-04-05
ES513277A0 (es) 1983-07-01
GB2102412B (en) 1985-01-09
NL193282B (nl) 1999-01-04
DK156054C (da) 1989-11-06

Similar Documents

Publication Publication Date Title
AU565908B2 (en) 7-oxabicyclo 2.2.1 hept-2-yl-5 alkyl/alkenyl carboxylic acids
DK0397420T3 (da) Enzymatisk fjernelse af en aminoterminal proteinsekvens
MC1990A1 (fr) Nouveaux derives du benzocycloheptene
DE2752720A1 (de) Substituierte aminosaeuren
EP0128602A3 (en) Retro-inverso analogues of the bradykinin potentiating peptide bpp5a and method for their preparation
EP0073143A2 (en) Novel complex amido and imido derivatives of carboxyalkyl peptides and thioethers and ethers of peptides
FI904204A0 (fi) Foerfarande foer framstaellning av cykliska aminosyraderivat och mellanprodukter.
DK162883D0 (da) N-glucosylerede carboxylsyreamidderivater, fremgangsmade til fremstilling heraf samt deres anvendelse til pavirkning af organismens egen forsvarsmekanisme
LU88361I2 (fr) Excenel
EP0236734A2 (de) Durch schwefelhaltigen Gruppen substituierte 5-Amino-4-hydroxyvalerylderivate
LV12291A (lv) Savienojums un farmaceitiskas kompozicijas ar triptazes aktivitates izmainam saistitu slimibu arstesanai
ZA817696B (en) N-substituted omega-(2-oxo-4-imidazolin-1-yl)alcanoic acids,salts and esters thereof,process for producing the same and these active agents containing pharmaceutical compounds
AU655288B2 (en) New triazolopyrimidine derivatives which are angiotensin II receptor antagonists; processes for preparing them and pharmaceutical compositions containing them
HUT34166A (en) Process for producing of imidazol-ethanol esthers
SE8207302L (sv) Nya 2-pyrrolidonforeningar och forfarande for framstellning av desamma
SE8307146L (sv) 7-oxabicykloheptan-substituerade aminoprostaglandinanaloger
GR861169B (en) Method for preparing n-(quinolyl) glycinamide derivatives and their application as psychotropes
SE8203814L (sv) Prolinderivat och forfarande for framstellning derav
HUT53664A (en) Process for producing enzyme inhibiting amino acid derivatives and pharmaceutical compositions comprising such compounds as active ingredient
ZA817698B (en) N-benzoyl-omega-anilino alkane carboxylic acids,salts and esters thereof,process for producing the same and pharmaceutical preparations containing the same
PT76934A (en) Process for the preparation of novel cetene-thio-acetals
ATE10099T1 (de) 3,8-dialkylxanthine, verfahren zu ihrer herstellung und diese enthaltende zusammensetzungen.
SE7701187L (sv) Nya piperazinderivat och sett att framstella desamma
JPS57209270A (en) Proline derivative
DE60133395D1 (de) Verfahren zur herstellung von alpha'-chlorketonen

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8203814-2

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8203814-2

Format of ref document f/p: F